Therapeutic Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection

• Principais autores: Yaeni Kim (Autor), Yu Ah Hong (Autor), Byung Ha Chung (Autor), Bum Soon Choi (Autor), Cheol Whee Park (Autor), Yeong Jin Choi (Autor), Yong-Soo Kim (Autor), Chul Woo Yang (Autor)
• Formato: Livro
• Publicado em: The Korean Society of Nephrology, 2014-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

While combination therapy of Rituximab (RTX) and intravenous immunoglobulin (IVIg) (RIT) has been proposed as therapeutic strategy for the treatment of chronic active antibody-mediated rejection (CAMR), its efficacy has not been established. In this study, we compared clinical outcome between the tr...